Poseida Therapeutics, Inc.
New Filing
CIK: 0001661460·Biotechnology·DELAWARE·Filed: Aug 11, 2023
Total Offering
$24,999,999
Amount Sold
$24,999,999
Investors
1
First Sale
Aug 7, 2023
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Mark J. Gergen | Related Person |
| Johanna M. Mylet | Related Person |
| Harry J. Leonhardt | Related Person |
| Brent Warner | Related Person |
| Kristin Yarema | Related Person |
| Rafael Amado | Related Person |
| Charles M. Baum | Related Person |
| Cynthia Collins | Related Person |
| Luke Corning | Related Person |
| Marcea B. Lloyd | Related Person |
| John Schmid | Related Person |
Company
SEC Filing
0001661460-23-000003
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free